BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15790359)

  • 1. Regulatory T cells and intestinal homeostasis.
    Coombes JL; Robinson NJ; Maloy KJ; Uhlig HH; Powrie F
    Immunol Rev; 2005 Apr; 204():184-94. PubMed ID: 15790359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.
    Erdman SE; Poutahidis T; Tomczak M; Rogers AB; Cormier K; Plank B; Horwitz BH; Fox JG
    Am J Pathol; 2003 Feb; 162(2):691-702. PubMed ID: 12547727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental mouse models of T cell-dependent inflammatory bowel disease.
    Song-Zhao GX; Maloy KJ
    Methods Mol Biol; 2014; 1193():199-211. PubMed ID: 25151008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of immune pathology by regulatory T cells.
    Powrie F; Read S; Mottet C; Uhlig H; Maloy K
    Novartis Found Symp; 2003; 252():92-8; discussion 98-105, 106-14. PubMed ID: 14609214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of intestinal inflammation by regulatory T cells.
    Singh B; Read S; Asseman C; Malmström V; Mottet C; Stephens LA; Stepankova R; Tlaskalova H; Powrie F
    Immunol Rev; 2001 Aug; 182():190-200. PubMed ID: 11722634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.
    Maloy KJ; Salaun L; Cahill R; Dougan G; Saunders NJ; Powrie F
    J Exp Med; 2003 Jan; 197(1):111-9. PubMed ID: 12515818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses.
    Powrie F
    Ann N Y Acad Sci; 2004 Dec; 1029():132-41. PubMed ID: 15681752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
    Powrie F; Uhlig H
    Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells.
    Maloy KJ; Antonelli LR; Lefevre M; Powrie F
    Immunol Lett; 2005 Mar; 97(2):189-92. PubMed ID: 15752557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-23 drives innate and T cell-mediated intestinal inflammation.
    Hue S; Ahern P; Buonocore S; Kullberg MC; Cua DJ; McKenzie BS; Powrie F; Maloy KJ
    J Exp Med; 2006 Oct; 203(11):2473-83. PubMed ID: 17030949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mucosal T lymphocytes in regulating intestinal inflammation.
    Uhlig HH; Powrie F
    Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.
    Maggio-Price L; Shows D; Waggie K; Burich A; Zeng W; Escobar S; Morrissey P; Viney JL
    Am J Pathol; 2002 Feb; 160(2):739-51. PubMed ID: 11839595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets.
    Maloy KJ
    Methods Mol Biol; 2007; 380():327-35. PubMed ID: 17876102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.
    Holmkvist P; Pool L; Hägerbrand K; Agace WW; Rivollier A
    Eur J Immunol; 2016 Jun; 46(6):1371-82. PubMed ID: 27062602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell transfer model of colitis: a great tool to assess the contribution of T cells in chronic intestinal inflammation.
    Eri R; McGuckin MA; Wadley R
    Methods Mol Biol; 2012; 844():261-75. PubMed ID: 22262449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.
    Burich A; Hershberg R; Waggie K; Zeng W; Brabb T; Westrich G; Viney JL; Maggio-Price L
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G764-78. PubMed ID: 11518689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector and regulatory lymphoid cells and cytokines in mucosal sites.
    MacDonald TT
    Curr Top Microbiol Immunol; 1999; 236():113-35. PubMed ID: 9893358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
    Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
    Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.